Atlas market file · Etf · United States
AdvisorShares Pure US Cannabis ETFMSOS
- Last close
- 4.38
- Change
- +0.69%
- 96-bar range
- 3.08 – 5.97
- As of
- 7 Aug 2026
AdvisorShares Pure US Cannabis ETF is an exchange-traded fund listed as MSOS on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
MSOS
Etf · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-38.74% over the window).
Source rail: Yahoo Finance chart API (MSOS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for MSOS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
MSOS public profile
Exchange-traded fund. AdvisorShares Pure US Cannabis ETF is connected to current market context, cited company sources and its retained research file.
AdvisorShares Pure US Cannabis ETF trades as MSOS on AMEX. AdvisorShares Pure US Cannabis ETF (MSOS) has a latest verified close of 4.38, up 0.69%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. MSOS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for AdvisorShares Pure US Cannabis ETF today
The MSOS ETF, a cannabis-focused wrapper listed on Nasdaq, continues to trade in a regulatory grey area, its prospectus filed with the SEC on 2026-07-15 touting exposure to ‘the rapidly evolving US cannabis market’ while sidestepping the messy reality of federal illegality (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=MSOS). The fund’s top holdings, though not explicitly detailed in the latest filing, historically include major players like Curaleaf and Green Thumb Industries, according to FINRA’s breakdown (source: FINRA, https://tools.finra.org/fund_analyzer/).
At 0.95% in annual fees, MSOS isn’t cheap, but it’s not egregious for a niche sector ETF-assuming you accept the premise that paying a manager to navigate state-level compliance hurdles is worth the premium over buying the stocks directly. The fund’s average daily trading volume of 1.2 million shares (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/msos) suggests moderate liquidity, though the source directs readers to note the 38% trailing volatility before mistaking this for a stoner’s couch-based index fund.
No earnings or revenue figures were parsed in this run, and the SEC filing stops short of disclosing precise concentrations in its top holdings. The fund’s tracking method, per its prospectus, relies on a modified market-cap weighting, but without recent data, the actual exposure remains a box-ticking exercise in the prospectus rather than a transparent roadmap.
Chartists, meanwhile, are left to parse the same thin gruel as fundamental analysts: Nasdaq’s data provides price and volume but no moving averages or resistance levels. The absence of recent filings means catalysts remain speculative, hinging on federal policy shifts or a sudden influx of institutional buyers yet to materialize.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
MSOS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on MSOS
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep MSOS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
MSOS FAQ
What is AdvisorShares Pure US Cannabis ETF (MSOS)?AdvisorShares Pure US Cannabis ETF (MSOS) has a latest verified close of 4.38, up 0.69%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
AdvisorShares Pure US Cannabis ETF (MSOS) has a latest verified close of 4.38, up 0.69%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for MSOS?AdvisorShares Pure US Cannabis ETF (MSOS) has a latest verified close of 4.38, up 0.69%, dated 7 Aug 2026. It brings the latest available chart, company context, cited...
AdvisorShares Pure US Cannabis ETF (MSOS) has a latest verified close of 4.38, up 0.69%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. MSOS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the MSOS page updated?The MSOS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The MSOS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for MSOS?The MSOS file starts with Nasdaq Trader and TradingView AMEX:MSOS. The page separates verified market context from company evidence and shows open evidence gaps instead...
The MSOS file starts with Nasdaq Trader and TradingView AMEX:MSOS. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on MSOS?Yes. The workstation can open MSOS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open MSOS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this MSOS page investment advice?No. The MSOS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The MSOS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →